Abstract
The invention provides a recombinant collagen or gelatin micro-carrier crosslinked by hexamethylenediisocyanate (HMDIC) comprising stromal cells for use in the treatment of cardiovascular disease. The invention is also directed at applications in which such cell carriers loaded with adipose derived stromal cells are used, for example as injectable cell carrier, for treatment of cardiovascular disease or treatment of damage of other tissues and organs.
| Original language | English |
|---|---|
| Patent number | WO2015122771 |
| Priority date | 13/02/2014 |
| Publication status | Published - 20-Aug-2015 |
Fingerprint
Dive into the research topics of 'Multipotent stromal cell loaded microcarriers'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver